Company Profile
- Stock Code
- RVMD
- ISIN Code
- US76155X1000
- Currency
- US Dollar (USD)
- IPO Date
- 2020-02-13

Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or...